However, in hyperleptinemia and subsequent development of leptin resistance, it fails to modulate appetite and exerts pro-inflammatory properties and, as such, is implicated not just in propagating obesity [48], but also in atherogenesis and arterial stiffness, thus increasing the risks for CVDs development [49]. The gene discussed is LEP; the disease is obesity disorder.